Ionis Pharmaceuticals Inc (NASDAQ:IONS)
| 49.40 Delayed Data As of Nov 29 |  +1.06 / +2.19%Today’s Change | 32.69 Today|||52-Week Range 50.39 | +30.79% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -88.3M | -86.6M | -17.3M | 215.0M | |
| Depreciation | 10.2M | 9.0M | 8.3M | 12.5M | ||
| Total Other Cash Flow | 78.6M | 117.0M | 139.5M | 166.5M | ||
| Funds From Operations | 554.0K | 39.4M | 130.6M | 103.5M | ||
| Funds From/For Other Operating Expenses | -20.6M | 151.5M | -43.6M | -499.4M | ||
| Net Cash Flow - Operating Activities | 21.1M | -112.1M | 174.1M | 602.9M | ||
| Investing | Increase In Investments | -493.5M | -300.9M | -880.3M | -1.8B | |
| Decrease In Investments | 445.2M | 369.0M | 559.9M | 882.8M | ||
| Capital Expenditures | -7.7M | -11.5M | -37.9M | -17.7M | ||
| Net Cash Flow Investing | -60.1M | 56.6M | -358.3M | -929.6M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 8.5M | 4.0M | 59.8M | 0.00 | ||
| Long Term Debt Reduction | -9.1M | -7.1M | -83.7M | 0.00 | ||
| Net Proceeds Stock Sale | 24.9M | 12.6M | 253.1M | 475.9M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 396.0K | 1.9M | 0.00 | 0.00 | ||
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 24.7M | 11.4M | 229.1M | 475.9M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -14.2M | -44.1M | 44.9M | 149.2M | ||
